Goldspan Health review
Two things shape this listing more than the sticker does. Goldspan publishes no figure anywhere on its own website — not on the homepage, not on the weight-loss category page — and every product instead links out to a separate storefront on another domain, where semaglutide finally reads $229 and tirzepatide $299, each paired with B12. That storefront then advertises the price as monthly while stating that a new supply arrives automatically every four weeks, which means thirteen charges a year rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 more than a monthly reading implies. Both figures were already at the higher end of the compounded market before that adjustment. The credit side is real enough: a longevity platform spanning eleven protocol categories, medication dispensed through licensed 503A and 503B pharmacies, and a flat price at any dose. The fifty-state claim on the homepage is qualified by the terms, which say some therapies are unavailable in some states.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Goldspan Health at a glance
- Semaglutide
- $229 per 4 weeks
- Tirzepatide
- $299 per 4 weeks
- Coverage
- All 50 states claimed, with exceptions in the terms
- Brand-name
- Compounded only
How we scored Goldspan Health
Each score comes out of Goldspan Health's published pricing, disclosures and oversight, and the six combine into the 32/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- September 2026
- Confidence
- medium
- Primary source
- goldspanhealth.com
Two things reshape the price before you get to it. Goldspan publishes no figure anywhere on its own website — you have to follow a product link out to a separate storefront to learn that semaglutide is $229 and tirzepatide $299. And that storefront bills every four weeks while calling it monthly, so a year is thirteen charges: about $2,977 and $3,887, roughly $230 and $300 more than twelve payments would suggest. Both were already among the pricier compounded options here. Medication is dispensed through licensed 503A and 503B pharmacies, and the fifty-state claim on the homepage is qualified by the terms.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $229 | Injection with B12, any dose⛔ Advertised as monthly but shipped and charged every 4 weeks — thirteen charges a year, about $2,977, not the $2,748 twelve payments imply. The figure appears nowhere on Goldspan's own site, only on the separate storefront its product links lead to. |
| Compounded tirzepatide | $299 | Injection with B12, any dose⛔ Same 4-week cycle: about $3,887 a year across thirteen charges rather than $3,588. Also priced only on the third-party storefront. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Goldspan Health's public disclosures at last review and change often; confirm the current number on Goldspan Health's own site.
What we like
- A flat price at any dose, so titrating up does not raise the bill
- Medication dispensed through licensed 503A and 503B pharmacies
- Sits inside a broad longevity platform of eleven protocol categories
- Both weight-loss protocols pair the molecule with B12 rather than selling it bare
The caveats
- No price appears anywhere on Goldspan's own site — you must click out to a third-party storefront
- Billed every 4 weeks while advertised as monthly, which is thirteen charges a year
- The real annual cost is about $2,977 and $3,887, not the $2,748 and $3,588 monthly reading
- Among the more expensive compounded GLP-1s here even before the cycle adjustment
- The homepage claims 50 states while the terms carve out exceptions
- Nothing addresses pregnancy, breastfeeding or postpartum timing
Goldspan Health for mothers: our verdict
Two things shape this listing more than the sticker does. Goldspan publishes no figure anywhere on its own website — not on the homepage, not on the weight-loss category page — and every product instead links out to a separate storefront on another domain, where semaglutide finally reads $229 and tirzepatide $299, each paired with B12. That storefront then advertises the price as monthly while stating that a new supply arrives automatically every four weeks, which means thirteen charges a year rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 more than a monthly reading implies. Both figures were already at the higher end of the compounded market before that adjustment. The credit side is real enough: a longevity platform spanning eleven protocol categories, medication dispensed through licensed 503A and 503B pharmacies, and a flat price at any dose. The fifty-state claim on the homepage is qualified by the terms, which say some therapies are unavailable in some states. It runs about $229/4 weeks, flat across every dose — a premium to the category, so the extras have to earn it.
We weigh Goldspan Health the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Goldspan Health actually costs
- Compounded semaglutide — Injection with B12, any dose: $229/4 wks
- Compounded tirzepatide — Injection with B12, any dose: $299/4 wks
For context, the typical ongoing price across our roster is around $179/month, so Goldspan Health sits at the premium end.
The medications Goldspan Health prescribes
Goldspan Health prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Goldspan Health fits — and where it doesn't — for mothers
Worth it if…
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Goldspan Health is a reasonable option — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A family already buying peptide protocols who wants a GLP-1 on the same platform, and who will do the thirteen-payment arithmetic before comparing it with a monthly seller.
Alternatives to Goldspan Health
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Goldspan Health
Head-to-head & alternatives
Goldspan Health, answered
- Why is there no price on the website?
- Because there genuinely is not one. Goldspan's homepage and weight-loss category page carry no dollar figure at all. Every product links out to a separate storefront on another domain, and only there does a price appear — $229 for semaglutide and $299 for tirzepatide, both with B12. Buying from one company through another company's checkout is worth knowing before you start.
- What does billing every four weeks cost me?
- About one extra payment a year. The storefront advertises monthly pricing but states that a new supply arrives automatically every four weeks, which is thirteen shipments a year rather than twelve. Semaglutide works out to roughly $2,977 a year instead of $2,748, and tirzepatide to about $3,887 instead of $3,588 — around $230 and $300 more than a monthly reading suggests.
- Is it available everywhere?
- Not quite, by its own account. The homepage says "In 50 states" and the terms then say some therapies are unavailable in certain states. The claim and the qualification sit in different documents, so check that the specific protocol you want is offered where you live rather than trusting the headline.
Pricing, states and verification reflect Goldspan Health's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.